Aron-Wisnewsky, Judith
Vigliotti, Chloé
Witjes, Julia
Le, Phuong
Holleboom, Adriaan G.
Verheij, Joanne
Nieuwdorp, Max
Clément, Karine http://orcid.org/0000-0002-2489-3355
Article History
Accepted: 21 January 2020
First Online: 9 March 2020
Competing interests
: M.N. is in the Scientific Advisory Board of Caelus Pharmaceuticals, the Netherlands. K.C. is on the Scientific Advisory Board of LNC therapeutics and CONFO therapeutics and has contract consultancy and contract collaboration with Danone Research. None of these are directly relevant to the current paper. There are no patents, products in development or marketed products to declare. The other authors declare no competing financial interests.